<DOC>
	<DOCNO>NCT01981681</DOCNO>
	<brief_summary>PF-06263276 first class inhibitor Janus kinase ( JAK ) enzymes 1 , 2 , 3 tyrosine kinase 2 ( TYK2 ) develop treatment chronic plaque psoriasis . The goal study assess safety , local tolerability , pharmacokinetics healthy subject .</brief_summary>
	<brief_title>A Phase 1 Study To Evaluate Tolerability , Safety , And Pharmacokinetics Of Topical PF-06263276 In Healthy Subjects</brief_title>
	<detailed_description />
	<criteria>Healthy male and/or female subject nonchildbearing potential age 18 55 year , inclusive . Healthy define clinically relevant abnormality identify detailed medical history , full physical examination , include blood pressure pulse rate measurement , 12lead ECG clinical laboratory test . Subjects willing able comply schedule visit , treatment plan , laboratory test , study procedure . Subjects willing avoid tanning bed sun exposure back study . Evidence history clinically significant hematological , renal , endocrine , pulmonary , gastrointestinal , cardiovascular , hepatic , psychiatric , neurologic , allergic disease ( include drug allergy , exclude untreated , asymptomatic , seasonal allergy time application ) . Subjects active skin condition application site possibly affect drug absorption ( e.g . rash , sun burn , scar , tattoo ) . Subjects Draize score &gt; 0 test area ( back ) immediately prior first treatment application . Subjects use topical prescription nonprescription drugs/over counter preparation back within 14 day first treatment application . Subjects willing avoid application treatmentssuch lotion cream back throughout study followup .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Phase 1</keyword>
	<keyword>Randomized</keyword>
	<keyword>Placebo-Controlled</keyword>
	<keyword>Multiple Dose Escalation</keyword>
	<keyword>Tolerability</keyword>
	<keyword>Safety</keyword>
	<keyword>PK</keyword>
	<keyword>Topical</keyword>
	<keyword>Healthy</keyword>
	<keyword>PF-06263276</keyword>
</DOC>